AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 3.42 |
Market Cap | 453.43M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -2.88 |
PE Ratio (ttm) | -1.36 |
Forward PE | n/a |
Analyst | Hold |
Ask | 4.7 |
Volume | 231,455 |
Avg. Volume (20D) | 417,519 |
Open | 3.97 |
Previous Close | 3.93 |
Day's Range | 3.88 - 4.03 |
52-Week Range | 3.19 - 10.62 |
Beta | undefined |
About DH
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinica...
Analyst Forecast
According to 10 analyst ratings, the average rating for DH stock is "Hold." The 12-month stock price forecast is $5, which is an increase of 27.39% from the latest price.
Next Earnings Release
Analysts project revenue of $60.59M, reflecting a -8.1% YoY shrinking and earnings per share of 0.07, making a 0.00% YoY.
3 weeks ago · https://thefly.com
Definitive Healthcare initiated with an Equal Weight at StephensStephens initiated coverage of Definitive Healthcare with an Equal Weight rating and $5 price target. Definitive has "an impressive collection of data assets that have attracted a marquee customer bas...
2 months ago · seekingalpha.com
Definitive Healthcare Corp. (DH)) Q3 2024 Earnings Call TranscriptDefinitive Healthcare Corp. (NASDAQ:DH ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Matt Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Richa...